Cart
sales@molnova.com
BIBR 1087 SE
CAS No. 212321-78-3
BIBR 1087 SE( Desethyl Dabigatran Etexilate )
Catalog No. M23967 CAS No. 212321-78-3
BIBR 1087 SE is a metabolite of dabigatran etexilate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 83 | In Stock |
|
| 5MG | 135 | In Stock |
|
| 10MG | 237 | In Stock |
|
| 25MG | 500 | In Stock |
|
| 50MG | 718 | In Stock |
|
| 100MG | 981 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBIBR 1087 SE
-
NoteResearch use only, not for human use.
-
Brief DescriptionBIBR 1087 SE is a metabolite of dabigatran etexilate.
-
DescriptionBIBR 1087 SE is a metabolite of dabigatran etexilate.
-
In Vitro——
-
In Vivo——
-
SynonymsDesethyl Dabigatran Etexilate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number212321-78-3
-
Formula Weight599.68
-
Molecular FormulaC32H37N7O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (166.76 mM)
-
SMILESO=C(N(C1=CC=CC=N1)CCC(O)=O)C2=CC=C(N(C)C(CNC3=CC=C(C(NC(OCCCCCC)=O)=N)C=C3)=N4)C4=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stangier J, et al. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment. J Clin Pharmacol. 2008 Dec;48(12):1411-9.
molnova catalog
related products
-
Influenza NP (482 - ...
Influenza NP (482 - 489)
-
(Arg)9 TFA
(Arg)9 TFA (Nona-L-arginine TFA), a cell-penetrating peptide, exhibits neuroprotective activity with an IC50 of 0.78 μM in the glutamic acid model.Poly-arginine (e.g. (Arg)9) and arginine-rich peptides (e.g. TAT, penetratin), which belong to a class of peptides with cell-penetrating properties are neuroprotective.
-
WSP-1
WSP-1 is a selective 2-pyridyl disulfide fluorescent probe for hydrogen sulfide detection and bioimaging.
